Clin Exp Otorhinolaryngol.  2022 Aug;15(3):201-202. 10.21053/ceo.2022.00997.

Clinical Applications of Human Nasal Organoids

• Kim DH
• Kim SW

• KMID: 2532982
• DOI: http://doi.org/10.21053/ceo.2022.00997

Reference

1. Hogan BL, Barkauskas CE, Chapman HA, Epstein JA, Jain R, Hsia CC, et al. Repair and regeneration of the respiratory system: complexity, plasticity, and mechanisms of lung stem cell function. Cell Stem Cell. 2014; Aug. 15(2):123–38.

2. Huang SX, Green MD, de Carvalho AT, Mumau M, Chen YW, D’Souza SL, et al. The in vitro generation of lung and airway progenitor cells from human pluripotent stem cells. Nat Protoc. 2015; Mar. 10(3):413–25.

3. Hynds RE, Butler CR, Janes SM, Giangreco A. Expansion of human airway basal stem cells and their differentiation as 3D tracheospheres. Methods Mol Biol. 2019; 1576:43–53.

4. Kotton DN, Morrisey EE. Lung regeneration: mechanisms, applications and emerging stem cell populations. Nat Med. 2014; Aug. 20(8):822–32.

5. Hui KP, Ching RH, Chan SK, Nicholls JM, Sachs N, Clevers H, et al. Tropism, replication competence, and innate immune responses of influenza virus: an analysis of human airway organoids and ex-vivo bronchus cultures. Lancet Respir Med. 2018; Nov. 6(11):846–54.

6. Sachs N, Papaspyropoulos A, Zomer-van Ommen DD, Heo I, Bottinger L, Jonkers J, et al. Long-term expanding human airway organoids for disease modeling. EMBO J. 2019; Feb. 38(4):e100300.

7. Tan Q, Choi KM, Sicard D, Tschumperlin DJ. Human airway organoid engineering as a step toward lung regeneration and disease modeling. Biomaterials. 2017; Jan. 113:118–32.

8. Zhou J, Li C, Sachs N, Chiu MC, Wong BH, Chu H, et al. Differentiated human airway organoids to assess infectivity of emerging influenza virus. Proc Natl Acad Sci U S A. 2018; Jun. 115(26):6822–7.

9. Hild M, Jaffe AB. Production of 3-D Airway organoids from primary human airway basal cells and their use in high-throughput screening. Curr Protoc Stem Cell Biol. 2016; May. 37:IE.9.1–IE.9.15.